These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11325765)

  • 1. Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study.
    Cosmi B; Legnani C; Bernardi F; Coccheri S; Palareti G
    BMJ; 2001 Apr; 322(7293):1024-5. PubMed ID: 11325765
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.
    Cosmi B; Legnani C; Bernardi F; Coccheri S; Palareti G
    Arch Intern Med; 2003 May; 163(9):1105-9. PubMed ID: 12742811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
    Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
    Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden and contraception.
    Ament L
    J Midwifery Womens Health; 2004; 49(1):51-2. PubMed ID: 14710141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism.
    Bates SM; Ginsberg JS; Straus SE; Rekers H; Sackett DL
    CMAJ; 2000 Oct; 163(8):1016-21. PubMed ID: 11068575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is family history sufficient to identify women with risk of venous thromboembolism before commencing the contraceptive pill?
    Aznar J; Mira Y; Vayá A; Ferrando F; Villa P
    Clin Appl Thromb Hemost; 2002 Apr; 8(2):139-41. PubMed ID: 12121054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
    DeSancho MT; Dorff T; Rand JH
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis?
    Sapp AV; Lindbloom EJ
    J Fam Pract; 2001 Oct; 50(10):893. PubMed ID: 11674894
    [No Abstract]   [Full Text] [Related]  

  • 10. [Risk of venous thromboembolism among users of third-generation oral contraceptives].
    Vallée JP
    Presse Med; 2001 Mar; 30(11):535-6. PubMed ID: 11317930
    [No Abstract]   [Full Text] [Related]  

  • 11. Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women.
    Dulícek P; Malý J; Pecka M; Beránek M; Cermáková E; Malý R
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):567-73. PubMed ID: 19117968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The third generation pill controversy ("continued").
    Drife JO
    BMJ; 2001 Jul; 323(7305):119-20. PubMed ID: 11463662
    [No Abstract]   [Full Text] [Related]  

  • 13. Venous thromboembolism and oral contraceptives.
    D'Souza R; Guillebaud J
    Lancet; 1999 Oct; 354(9188):1469; author reply 1469-70. PubMed ID: 10543690
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening women for oral contraception: can family history identify inherited thrombophilias?
    Grimes DA; Stuart GS; Levi EE
    Obstet Gynecol; 2012 Oct; 120(4):889-95. PubMed ID: 22996107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism and oral contraceptives.
    Lewis MA; MacRae KD; Kühl-Habich D; Heinemann LA
    Lancet; 1999 Oct; 354(9188):1470. PubMed ID: 10543691
    [No Abstract]   [Full Text] [Related]  

  • 16. Venous thromboembolism and oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Vandenbroucke JP
    Lancet; 1999 Oct; 354(9188):1469; author reply 1469-70. PubMed ID: 10543689
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral contraceptives, venous thromboembolism, and the courts.
    Skegg DC
    BMJ; 2002 Sep; 325(7363):504-5. PubMed ID: 12217976
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of venous thromboembolism in relatives of symptomatic probands with thrombophilia: a systematic review.
    Langlois NJ; Wells PS
    Thromb Haemost; 2003 Jul; 90(1):17-26. PubMed ID: 12876621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism.
    Andersen BS; Olsen J; Nielsen GL; Steffensen FH; Sørensen HT; Baech J; Gregersen H
    Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
    Mills A; Wilkinson C; Fotherby K
    Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.